Company Filing History:
17 out of 74 
6 out of 122 
6 out of 13 Years Active: 2006-2023
Title: The Innovative Contributions of Stefan Schulte in Hemophilia Treatment
Introduction
Stefan Schulte, an accomplished inventor based in Marburg, Germany, has made significant strides in the field of biomedical research and therapeutic innovations. With a remarkable portfolio of 30 patents, his work primarily focuses on developing treatments for blood coagulation disorders, benefiting many patients suffering from hemophilia.
Latest Patents
Among his latest inventions are two notable patents. The first one focuses on **Truncated von Willebrand Factor polypeptides for treating hemophilia**, which pertains to a polypeptide comprising a truncated von Willebrand Factor (VWF) along with a half-life extending moiety. This invention aims to treat blood coagulation disorders by administering the polypeptide to individuals with reduced endogenous Factor VIII (FVIII) levels. The polypeptide not only binds to endogenous FVIII but also enhances its activity level, thus improving the patient's condition.
The second significant patent addresses **Methods for preparing modified von Willebrand Factor**. This invention includes modified von Willebrand Factor molecules, their preparation methods, and the pharmaceutical compositions intended for treating coagulation disorders. Together, these innovations demonstrate Schulte's impact on advancing hemophilia treatment.
Career Highlights
Stefan Schulte has an impressive career marked by his tenures at prominent organizations such as CSL Behring GmbH and CSL Limited. His work at these companies has provided him with the platform to develop vital innovations that address critical health issues related to blood coagulation disorders. These experiences have significantly enriched his expertise and contribute to his success as an inventor.
Collaborations
Throughout his career, Schulte has collaborated with professionals who share his passion for innovation. Notable coworkers include Thomas Weimer and Hubert Metzner, both of whom have also contributed to advancements in the biomedical field. Such collaborations have played a crucial role in enhancing the efficacy and applicability of his inventions, fostering a spirit of teamwork that drives progress.
Conclusion
Stefan Schulte's work exemplifies the power of innovation in addressing complex medical challenges like hemophilia. With his extensive experience and impressive patent portfolio, he continues to make substantial contributions that enhance the quality of life for individuals affected by blood coagulation disorders. His dedication to research and development serves as an inspiration for future inventors and researchers in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.